月營收 · 2025-08 · 共 1,973 家
最近更新：11-02 06:16
排序：1.當月營收↓ — 點欄位 ▲▼ 可疊加多欄（數字＝優先序）
| 股票 | 當月營收(億)▲▼ | MoM▲▼ | YoY▲▼ | 公布日期▲▼ | 備註 |
|---|---|---|---|---|---|
| 0.53 | -29.37% | -41.71% | — | ||
| 0.53 | -2.68% | -31.86% | — | ||
| 0.53 | -6.60% | -10.44% | — | ||
| 0.53 | -1.10% | -8.23% | — | ||
| 0.52 | -6.31% | +7.26% | — | ||
| 0.52 | +49.34% | +31.65% | — | 印度大型機台成長 | |
| 0.52 | -36.69% | -65.56% | — | 主產品帕金森氏症與憂鬱症藥物Q3因客戶沒下單致營收減少，預計Q4會回復供貨﹔另其他產品因市場競爭致使接單狀況亦不理想。 | |
| 0.52 | -5.89% | -57.97% | — | 主係受匯率及國際市場環境影響所致 | |
| 0.52 | -6.35% | -11.62% | — | ||
| 0.52 | +6.01% | +15.26% | — | ||
| 0.52 | +36.04% | +5.49% | — | ||
| 0.51 | +6.80% | -14.27% | — | ||
| 0.51 | -11.84% | -16.91% | — | ||
| 0.51 | +3.73% | -19.88% | — | ||
| 0.51 | -1.74% | -1.36% | — | ||
| 0.51 | +33.75% | +0.56% | — | ||
| 0.50 | -6.03% | +35.69% | — | ||
| 0.50 | -1.47% | -15.33% | — | ||
| 0.50 | -1.08% | -20.35% | — | ||
| 0.50 | +77.34% | +72.68% | — | 租金收入增加所致 | |
| 0.50 | -4.99% | -11.56% | — | ||
| 0.50 | +1.51% | -0.83% | — | ||
| 0.50 | +0.78% | +21.80% | — | ||
| 0.50 | -13.28% | -17.29% | — | ||
| 0.50 | -11.79% | -4.55% | — | ||
| 0.49 | -8.28% | -13.11% | — | ||
| 0.49 | +63.41% | -30.22% | — | ||
| 0.49 | -11.97% | +1.04% | — | ||
| 0.49 | +1.51% | +51.60% | — | 產品需求較去年顯著成長。 | |
| 0.49 | -7.51% | -9.80% | — | ||
| 0.48 | -9.63% | -10.35% | — | ||
| 0.48 | -33.60% | -46.04% | — | ||
| 0.47 | +14.03% | -7.51% | — | 配合客戶裝機 | |
| 0.47 | +6.12% | -33.43% | — | ||
| 0.47 | -5.08% | +6.63% | — | ||
| 0.47 | -14.67% | -24.60% | — | ||
| 0.47 | -4.83% | -6.65% | — | ||
| 0.47 | +40.30% | +93.97% | — | 客戶需求增加，主係因癌症檢測及儀器銷售增加所致 | |
| 0.47 | -26.29% | -4.34% | — | ||
| 0.47 | +33.89% | -4.07% | — | ||
| 0.47 | -13.35% | -19.73% | — | ||
| 0.46 | +28.09% | -15.94% | — | ||
| 0.46 | -15.65% | -17.25% | — | ||
| 0.46 | -26.27% | -33.83% | — | ||
| 0.46 | -18.21% | -17.60% | — | ||
| 0.46 | -57.18% | -1.49% | — | ||
| 0.45 | -37.74% | -70.89% | — | 當月營收較去年同期減少，主係部份產品因應市場變化調整供貨。 | |
| 0.45 | +2.84% | -23.08% | — | ||
| 0.45 | +56.91% | -11.98% | — | ||
| 0.45 | +4.10% | +13.23% | — | ||
| 0.45 | -17.45% | -12.82% | — | ||
| 0.44 | +21.19% | +2.42% | — | ||
| 0.44 | -29.29% | -78.79% | — | 本月營業收入受市場狀況影響，營收減少。 | |
| 0.44 | +235.04% | +1470.28% | — | 依客戶交期出貨致使本期較上期增加 | |
| 0.44 | -25.42% | -39.04% | — | ||
| 0.44 | +3.28% | +70.55% | — | 受惠於歐美客戶拉貨動能暢旺影響，致使本月銷售量較去年同期顯著提升。 | |
| 0.44 | +17.03% | -5.11% | — | ||
| 0.44 | +3.68% | -21.76% | — | ||
| 0.44 | +1.39% | +2.53% | — | ||
| 0.44 | -4.98% | +42.27% | — | ||
| 0.44 | +44.30% | +23.45% | — | ||
| 0.43 | -8.53% | +6.54% | — | ||
| 0.43 | -57.29% | -91.41% | — | 營收隨完工案量多寡而變化乃屬建設業特性，故本期及本年業績大幅衰退尚屬合理。 | |
| 0.43 | -45.91% | -63.31% | — | 本公司之主要產品須通過國防部之軍品認證，認證完成後才能取得相關訂單。目前已陸續進行軍品認證，認證通過後將陸續取得訂單。 | |
| 0.43 | +8.49% | +4.96% | — | ||
| 0.43 | +2.76% | -5.70% | — | ||
| 0.43 | -22.11% | -12.00% | — | 本年累計較去年累計高，主係因114年05月有數台核子醫學相關大設備驗收所致。 | |
| 0.43 | +17.28% | +2.37% | — | ||
| 0.42 | +19.78% | +18.40% | — | ||
| 0.42 | +5.10% | +12.09% | — | ||
| 0.42 | +0.52% | +35.67% | — | ||
| 0.42 | -2.76% | -16.66% | — | ||
| 0.42 | -25.88% | +49.95% | — | ||
| 0.42 | +1.84% | +30.84% | — | ||
| 0.42 | -3.57% | +15.21% | — | ||
| 0.42 | -19.71% | -20.85% | — | ||
| 0.42 | +20.79% | -44.85% | — | ||
| 0.41 | -40.34% | -13.73% | — | ||
| 0.41 | -19.73% | +101.50% | — | 市場需求漸回溫 | |
| 0.41 | -21.21% | -28.77% | — | ||
| 0.40 | -31.60% | +14.89% | — | ||
| 0.40 | -10.66% | -42.39% | — | 因市場需求下降 | |
| 0.39 | +20.94% | -3.36% | — | ||
| 0.39 | -6.22% | +174.29% | — | 訂單量增多 | |
| 0.39 | -29.36% | -16.80% | — | ||
| 0.39 | -17.37% | +19.44% | — | ||
| 0.39 | +5.83% | +15.09% | — | ||
| 0.39 | -23.68% | -19.61% | — | ||
| 0.38 | +745.12% | +233.91% | — | 太陽能及儲能系統建置:銷貨額$35,147,388;售電:銷貨額$1,692,966 | |
| 0.38 | +2.00% | -9.07% | — | ||
| 0.38 | +48.88% | -8.10% | — | 因應產業趨勢調整客戶結構 | |
| 0.38 | -17.04% | -26.21% | — | ||
| 0.38 | -55.35% | -47.57% | — | ||
| 0.38 | -19.12% | -21.83% | — | ||
| 0.37 | -11.62% | -1.68% | — | ||
| 0.37 | -0.71% | -25.86% | — | ||
| 0.37 | -10.49% | +125.36% | — | 營收截至2025年8月止較去年累計上升主係光學分析儀, 呼吸道適應症多元檢測套組 以及腸胃道適應症多元檢測套組銷售增加所致。 | |
| 0.37 | +17.78% | +13.42% | — | ||
| 0.37 | +2.14% | -23.03% | — | ||
| 0.37 | -13.12% | -27.25% | — |
來源：MOPS 每月營收彙總表 t21sc03；公布日期為 FinMind create_time（逐步回填，「—」表示尚未取得）。